Drawing for THERASUIT

USPTO serial 76567656

THERASUIT

Reviewed by CopyMark Law Group

Reg. 3352814Status 711
Filing date
Status date
Registration date
Dec 11, 2007
Examiner
GARTNER, JOHN M
Law office
POST REGISTRATION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with THERASUIT?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

John D. Gugliotta

6100 OAK TREE BOULEVARDSUITE 200INDEPENDENCE, OH 44131

Goods and services

ClassDescriptionStatusFirst use
010Body suit for treatment of patients with disturbed posture and motor activitySECTION 7(e) - CANCELLEDApr 9, 2007

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Mar 10, 2008C7..CANCELLED SECTION 7-TOTAL—
Feb 22, 2008ALIEASSIGNED TO LIE—
Jan 28, 2008C7RFREQUEST FOR SECT 7 TOTAL SURRENDER FILED—
Jan 28, 2008FAXXFAX RECEIVED—
Dec 11, 2007R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Nov 5, 2007REGVLAW OFFICE REGISTRATION REVIEW COMPLETED—
Nov 5, 2007ALIEASSIGNED TO LIE—
Oct 2, 2007CNPRALLOWED PRINCIPAL REGISTER - SOU ACCEPTED—
Oct 1, 2007SUPCSTATEMENT OF USE PROCESSING COMPLETE—
Aug 31, 2007PGSUPETITION GRANTED - SOU FILED—
Jul 25, 2007PETRPETITION TO REVIVE-RECEIVED—
Jul 25, 2007MAILPAPER RECEIVED—
Jul 13, 2007TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Jul 13, 2007TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Feb 28, 2007MAB6ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Feb 28, 2007ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Dec 14, 2006IUAFUSE AMENDMENT FILED—
Jul 14, 2006EX3GSOU EXTENSION 3 GRANTED—
Jun 12, 2006EXT3SOU EXTENSION 3 FILED—
Jun 12, 2006MAILPAPER RECEIVED—
Dec 12, 2005DMCCDATA MODIFICATION COMPLETED—
Dec 12, 2005MAILPAPER RECEIVED—
Jun 15, 2005EX2GSOU EXTENSION 2 GRANTED—
Jun 15, 2005EXT2SOU EXTENSION 2 FILED—
Jun 15, 2005MAILPAPER RECEIVED—
Apr 22, 2005EX1GSOU EXTENSION 1 GRANTED—
Mar 21, 2005EXT1SOU EXTENSION 1 FILED—
Mar 21, 2005MAILPAPER RECEIVED—
Dec 14, 2004NOAMNOA MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Sep 21, 2004PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Sep 1, 2004NPUBNOTICE OF PUBLICATION—
Jul 14, 2004CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jul 13, 2004CNEAEXAMINER'S AMENDMENT MAILED—
Jul 12, 2004DOCKASSIGNED TO EXAMINER—
Jan 13, 2004NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance